Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-oriented Exercise Therapy for Oncological Patients

NCT ID: NCT06185777

Last Updated: 2025-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

2500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-01

Study Completion Date

2027-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

MOVE-ONKO is developing and implementing a guideline-based, multi-professional care pathway for the promotion and therapy of exercise for cancer patients. This pathway intended to serve as an interface between oncological care and existing or developing exercise therapy services in the local area of the participating hospitals. Needs- and side-effect-oriented care pathways are intended to give as many patients as possible access to quality-assured exercise therapy services close to home and thus to the supportive potential of exercise. The new care pathway will be develop in year 1 (phase 1) and will be established at 7 Comprehensive Cancer Centers (CCCs) in 3 model regions Heidelberg-Frankfurt-Mainz, Dresden-Berlin and Freiburg-Tübingen (phase 2) in Germany, as well as adapted accordingly in organ cancer centers and with established oncological care providers (phase 3 - Outreach). The aim is to ensure that exercise promotion and therapy can be integrated into standard care as comprehensively and sustainably as possible.

The implementation project will be evaluated according to the achievement of implementation and intervention goals. The implementation goals are utilization (reach) and actual implementation. Factors for successful implementation will be identified and incorporated into the procedure in phase 3 (outreach). Intervention goals are mapped at provider and patient level in both phases. They include improving physical functioning, increasing physical activity behavior, improving exercise-related health literacy, increasing motivation to exercise and increasing patient participation. For this purpose, patients with a cancer disease undergoing acute therapy aged 18 and over who are cared for in participating centers are surveyed four times over a period of 24 weeks using standardized questionnaires (baseline (t0) before the intervention, follow-up after 4 (t1), 12 (t2) and 24 (t3) weeks). In addition, the participating managers and service providers of the centers in phase 2 (implementation phase) and phase 3 (outreach phase) will be surveyed using standardized questionnaires and in-depth interviews. The longitudinal evaluation design enables an analysis of the changes in care structures and processes, the success of implementation and the experiences and outcomes of patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Exercise Implementation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exercise oncology counseling and referal

Identification \& brief consultation Screening: Needs assessment for exercise therapy Information / educational talk Consultation with the patient Risk assessment (with physician clearance) Consultation Referral to exercise therapy

Group Type EXPERIMENTAL

Exercise oncology counseling and referal

Intervention Type BEHAVIORAL

Identification \& brief consultation Screening: Needs assessment for exercise therapy Information / educational talk Consultation with the patient Risk assessment (with physician clearance) Consultation Referral to exercise therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise oncology counseling and referal

Identification \& brief consultation Screening: Needs assessment for exercise therapy Information / educational talk Consultation with the patient Risk assessment (with physician clearance) Consultation Referral to exercise therapy

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cancer patients during chemotherapy, immune therapy or radiotherapy
* having symptoms/side effects that can be effectively treated by exercise (e.g. fatigue) and/or are interested in exercise oncology counseling


\- involved in the implementation process

Exclusion Criteria

\- Insufficient German language skills


\- Duration employed \<6 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Heidelberg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Joachim Wiskemann

Prof. Dr. Joachim Wiskemann

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitätsklinikum Freiburg

Freiburg im Breisgau, Baden-Wurttemberg, Germany

Site Status RECRUITING

Nationales Centrum für Tumorerkrankungen

Heidelberg, Baden-Wurttemberg, Germany

Site Status RECRUITING

Medizinische Klinik der Universitätsklinikum Tübingen

Tübingen, Baden-Wurttemberg, Germany

Site Status RECRUITING

Universitäres Centrum für Tumorekrankungen Frankfurt

Frankfurt am Main, Hesse, Germany

Site Status RECRUITING

Universitäres Centrum für Tumorerkrankungen Mainz

Mainz, Rhineland-Palatinate, Germany

Site Status RECRUITING

Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC)

Dresden, Saxony, Germany

Site Status RECRUITING

Charité - Universitätsmedizin Berlin

Berlin, State of Berlin, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Joachim Wiskemann, Prof

Role: CONTACT

+49 6221 565904

Julia Albrecht, Dr

Role: CONTACT

+49 6221 56-32630

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tanja Sprave, Dr

Role: primary

+49 761 270-95200|

Joachim Wiskemann, Prof.

Role: primary

+49 6221 56 5904

Andreas Nieß, Prof.

Role: primary

+49 7071-29 86472

Katharina Graf, Dr

Role: primary

+49 69 7601 3380

Ulrich Betz, Dr.

Role: primary

+49 6131 17-2356

Martin Bornhäuser, Prof.

Role: primary

+351 458 4190

Bernd Wolfarth, Prof.

Role: primary

+49 30 2093-46053

References

Explore related publications, articles, or registry entries linked to this study.

Blutgen S, Krug K, Graf K, Betz U, Bohm J, Jager E, Krell V, Muller J, Pahl A, Voland A, Weigmann-Fassbender S, Zinkevich A, Wensing M, Ansmann L, Wiskemann J. Implementation and evaluation of a multi-professional care pathway and network for the promotion of needs-oriented, resident-oriented exercise therapy for oncological patients (MOVE-ONKO): protocol of a mixed-methods cohort study. BMC Cancer. 2025 Mar 13;25(1):458. doi: 10.1186/s12885-025-13797-7.

Reference Type DERIVED
PMID: 40082847 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://move-onko.de/

Project Website (in German only)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S-571/2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rehabilitation - Physical Activity and Coping
NCT04245943 ACTIVE_NOT_RECRUITING NA
Rehabilitation Outcomes Study
NCT06674889 RECRUITING NA